The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Abstract
Thyroid carcinoma is rare among human malignancies (<1%) but is the most frequent endocrine cancer, accounting for about 5% of thyroid nodules (1). The latter are very frequent in the general population and, according to the method of detection and the age of the patients, their prevalence may approach 20–50% of the general population, thus representing a daily issue in endocrine clinics. Furthermore, the incidence of thyroid cancer, mainly differentiated, is one of the most rapidly increasing human cancers, at least in the United States (2), with the papillary histotype being the most frequent (nearly 80%). There is a need for uniform diagnostic and treatment strategies for thyroid nodules and differentiated thyroid cancer (DTC) since the disease requires a multidisciplinary approach, including endocrinology, internal medicine, nuclear medicine, oncology, endocrine (general or head and throat) surgery and even general practice operating in different settings not always equipped with the appropriate services (such as specialized centers, general hospitals and peripheral centers). Not infrequently among European countries, epidemiology may differ according to different environment, probably reflecting different clinical practice or pathogenetic factors, which may change the presentation and the management strategy. In addition, in recent decades, the clinical presentation of differentiated thyroid cancer has been changing from advanced cases requiring intense treatment and surveillance to cancers detected by fortuitous neck ultrasonography (US) requiring less aggressive treatment and follow-up. Diagnostic and treatment tools have also improved in recent years (sensitive assays for serum thyroglobulin measurement, neck US, recombinant human thyrotropin (rhTSH)), thus allowing for less invasive and uncomfortable procedures for the patients. Altogether, these considerations dictate the need for applying the more effective, less invasive and less expensive procedures able to guarantee the best management and the best quality of life for a disease that, albeit having an intrinsic low mortality, requires life-long follow-up care. Several European countries have developed their own guidelines or consensus reports (3–6), based on consolidated experience and cultural attitude of the country. Nevertheless, they differ in several, sometimes important, aspects. Following the spirit of concrete cultural and scientific integration among the countries participating in the new reality of the European Union, the European Thyroid Association (ETA) has endorsed the implementation of this consensus for the management of thyroid nodules and DTC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
Mazzaferri, E. L., & Jhiang, S. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90321-2 · Cited by 2,635
Frates, M. C., Benson, C. B., Charboneau, J. W., Cibas, E. S., Clark, O. H., Coleman, B. G., Cronan, J. J., Doubilet, P. M., Evans, D. B., Goellner, J. R., et al. (2005) · Radiology · doi:10.1148/radiol.2373050220 · Cited by 1,227
HAY, I. D., Bergstralh, E. J., Goellner, J. R., Ebersold, J. R., & Grant, C. S. (1993) · PubMed · Cited by 1,223
Second primary malignancies in thyroid cancer patients
Rubino, C., de Vathaire, F., Dottorini, M. E., Hall, P., Schvartz, C., Couette, J. E., Dondon, M. G., Abbas, M. T., Langlois, C., & Schlumberger, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601319 · Cited by 655
Self-citationMazzaferri, E. L., Robbins, R. J., Spencer, C. A., Braverman, L. E., Pacini, F., Wartofsky, L., Haugen, B. R., Sherman, S. I., Cooper, D. S., Braunstein, G. D., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021702 · Cited by 654
Self-citationSamaan, N. A. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.714 · Cited by 615
Haugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P. W., Sherman, S. I., Cooper, D. S., Graham, K. E., Braverman, L. E., Skarulis, M. C., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6094 · Cited by 566
Self-citationA prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative group
Byar, D. P., Green, S. B., Dor, P., Williams, E. D., Colon, J., van Gilse, H. A., Mayer, M., Sylvester, R. J., & Van Glabbeke, M. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90291-3 · Cited by 554
Elisei, R., Bottici, V., Luchetti, F., Di Coscio, G., Romei, C., Grasso, L., Miccoli, P., Iacconi, P., Basolo, F., Pinchera, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030550 · Cited by 537
Self-citationBelfiore, A., Rosa, G. L. L., Porta, G. A. L., Giuffrida, D., Milazzo, G., Lupo, L., Regalbuto, C., & Vigneri, R. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90164-7 · Cited by 516
Hundahl, S. A., Cady, B., Cunningham, M. P., Mazzaferri, E., McKee, R. F., Rosai, J., Shah, J. P., Fremgen, A. M., Stewart, A. K., H�lzer, S., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1<202::aid-cncr27>3.0.co;2-a · Cited by 514
Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer
Machens, A., Hinze, R., Thomusch, O., & Dralle, H. (2002) · World Journal of Surgery · doi:10.1007/s00268-001-0176-3 · Cited by 508
Self-citationTNM residual tumor classification revisited
Wittekind, C., Compton, C. C., Greene, F. L., & Sobin, L. H. (2002) · Cancer · doi:10.1002/cncr.10492 · Cited by 507
Schlumberger, M. J., Vathaire, C. C.-D., de Vathaire, F., Travagli, J. P., Gardet, P., Lumbroso, J., Francese, C., Fontaine, F., Ricard, M., & Parmentier, C. (1996) · PubMed · Cited by 498
Self-citationScheumann, G. F. W., Gimm, O., Wegener, G., Hundeshagen, H., & Dralle, H. (1994) · World Journal of Surgery · doi:10.1007/bf00353765 · Cited by 493
Self-citationSawka, A. M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., & Gerstein, H. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031167 · Cited by 432
Pacini, F., Molinaro, E., Castagna, M. G., Agate, L., Elisei, R., Ceccarelli, C., Lippi, F., Taddei, D., Grasso, L., & Pinchera, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021925 · Cited by 428
Self-citationUsefulness of Ultrasonography in the Management of Nodular Thyroid Disease
Marqusee, E., Benson, C. B., Frates, M. C., Doubilet, P. M., Larsen, P. R., Cibas, E. S., & Mandel, S. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00011 · Cited by 412
National Thyroid Cancer Treatment Cooperative Study Registr Group, Sherman, S. I., Brierley, J. D., Sperling, M., Ain, K. B., Bigos, S. T., Cooper, D. S., Haugen, B. R., Ho, M., Klein, I., et al. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980901)83:5<1012::aid-cncr28>3.0.co;2-9 · Cited by 402
Radioactive Iodine and the Salivary Glands
Mandel, S. J., & Mandel, L. (2003) · Thyroid · doi:10.1089/105072503321582060 · Cited by 375
Machens, A., Holzhausen, H., & Dralle, H. (2005) · Cancer · doi:10.1002/cncr.21055 · Cited by 371
Self-citationDisappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens
Chiovato, L., Latrofa, F., Braverman, L. E., Pacini, F., Capezzone, M., Masserini, L., Grasso, L., & Pinchera, A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00010 · Cited by 364
Self-citationPineda, J. D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.5.1488 · Cited by 362
Cailleux, A. F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.175 · Cited by 357
COOPER, D. S., SPECKER, B., HO, M., SPERLING, M., LADENSON, P. W., ROSS, D. S., AIN, K. B., BIGOS, S. T., BRIERLEY, J. D., HAUGEN, B. R., et al. (1998) · Thyroid · doi:10.1089/thy.1998.8.737 · Cited by 353
Wang, W. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.7.2291 · Cited by 330
Hay, I. D., Grant, C. S., Bergstralh, E. J., Thompson, G. B., van Heerden, J. A., & Goellner, J. R. (1998) · Surgery · doi:10.1016/s0039-6060(98)70035-2 · Cited by 329
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
Schlumberger, M., Berg, G., Cohen, O., Duntas, L., Jamar, F., Jarzab, B., Limbert, E., Lind, P., Pacini, F., Reiners, C., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500105 · Cited by 327
Self-citationPacini, F. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1499 · Cited by 299
Self-citationBernier, M.-O. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1568 · Cited by 299
Baudin, E., Cao, C. D., Cailleux, A. F., Leboulleux, S., Travagli, J. P., & Schlumberger, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021365 · Cited by 278
Self-citationPrognostic factors and risk group analysis in follicular carcinoma of the thyroid
Shaha, A. R., Loree, T. R., & Shah, J. P. (1995) · Surgery · doi:10.1016/s0039-6060(05)80124-2 · Cited by 273
Pacini, F. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4092 · Cited by 268
Self-citationNiccoli, P. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.338 · Cited by 262
Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer
McGriff, N. J., Csako, G., Gourgiotis, L., Guthrie, L. C., Pucino, F., & Sarlis, N. J. (2002) · Annals of Medicine · doi:10.1080/078538902321117760 · Cited by 247
Torlontano, M., Attard, M., Crocetti, U., Tumino, S., Bruno, R., Costante, G., D’Azzò, G., Meringolo, D., Ferretti, E., Sacco, R., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031521 · Cited by 242
Goldstein, R. E., Netterville, J. L., Burkey, B., & Johnson, J. E. (2002) · Annals of Surgery · doi:10.1097/00000658-200205000-00007 · Cited by 236
Ito, Y., Tomoda, C., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Matsuzuka, F., Kuma, K., & Miyauchi, A. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7192-z · Cited by 228
Improved Survival of Patients with Papillary Thyroid Cancer after Surgical Microdissection
Tisell, L., Nilsson, B., Mölne, J., Hansson, G., Fjälling, M., Jansson, S., & Wingren, U. (1996) · World Journal of Surgery · doi:10.1007/s002689900130 · Cited by 227
Thyroid-hormone therapy and thyroid cancer: a reassessment
Biondi, B., Filetti, S., & Schlumberger, M. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0020 · Cited by 224
Self-citationPittas, A. G., Adler, M., Fazzari, M., Tickoo, S., Rosai, J., Larson, S. M., & Robbins, R. J. (2000) · Thyroid · doi:10.1089/thy.2000.10.261 · Cited by 224
Sherman, S. I. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.629 · Cited by 211
Schlumberger, M. J., Arcangioli, O., Piekarski, J. D., Tubiana, M., & Parmentier, C. (1988) · PubMed · Cited by 200
Self-citationSchlumberger, M. J., de Vathaire, F., Ceccarelli, C., Delisle, M. J., Francese, C., Couette, J. E., Pinchera, A., & Parmentier, C. (1996) · PubMed · Cited by 193
Self-citationRoutine Measurement of Plasma Calcitonin in Nodular Thyroid Diseases
Vierhapper, H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.5.1589 · Cited by 192
Preoperative staging of thyroid papillary carcinoma with ultrasonography
Shimamoto, K., Satake, H., Sawaki, A., Ishigaki, T., Funahashi, H., & Imai, T. (1998) · European Journal of Radiology · doi:10.1016/s0720-048x(97)00184-8 · Cited by 192
Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma
Taylor, T., Specker, B., Robbins, J., Sperling, M., Ho, M., Ain, K., Bigos, S. T., Brierley, J., Cooper, D., Haugen, B., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00007 · Cited by 192
Helal, B. O., Merlet, P., Toubert, M., Franc, B., Schvartz, C., Gauthier, H. K., Prigent, A., & Syrota, A. (2001) · PubMed · Cited by 189
Pacini, F. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5686 · Cited by 185
Self-citationMcWilliams, R. R., Giannini, C., Hay, I. D., Atkinson, J. L., Stafford, S. L., & Buckner, J. C. (2003) · Cancer · doi:10.1002/cncr.11488 · Cited by 181
(2005) · PubMed · Cited by 180
Luster, M., Lippi, F., Jarzab, B., Perros, P., Lassmann, M., Reiners, C., & Pacini, F. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00830 · Cited by 180
Self-citationOutcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
Pacini, F., Cetani, F., Miccoli, P., Mancusi, F., Ceccarelli, C., Lippi, F., Martino, E., & Pinchera, A. (1994) · World Journal of Surgery · doi:10.1007/bf00353775 · Cited by 175
Self-citationBeierwaltes, W. H., Nishiyama, R. H., Thompson, N. W., Copp, J., & Kubo, A. (1982) · PubMed · Cited by 171
Thyroid Cancer: Is the Incidence Still Increasing?
Hodgson, N. C., Button, J., & Solorzano, C. C. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.03.066 · Cited by 169
Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.
Pacini, F., Gasperi, M., Fugazzola, L., Ceccarelli, C., Lippi, F., Centoni, R., Martino, E., & Pinchera, A. (1994) · PubMed · Cited by 168
Self-citationLithium as a Potential Adjuvant to 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma
Koong, S.-S., Reynolds, J. C., Movius, E. G., Keenan, A. M., Ain, K. B., Lakshmanan, M. C., & ROBBINS, J. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5527 · Cited by 165
Zettinig, G., Fueger, B. J., Passler, C., Kaserer, K., Pirich, C., Dudczak, R., & Niederle, B. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01482.x · Cited by 164
Pacini, F., Elisei, R., Capezzone, M., Miccoli, P., Molinaro, E., Basolo, F., Agate, L., Bottici, V., Raffaelli, M., & Pinchera, A. (2001) · Thyroid · doi:10.1089/105072501316973145 · Cited by 156
Self-citationPluijmen, M. J. H. M., Eustatia‐Rutten, C. F. A., Goslings, B. M., Stokkel, M. P. M., Pereira, A. M., Diamant, M., Romijn, J. A., & Smit, J. W. A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01735.x · Cited by 150
Self-citationRobbins, R. J., Larson, S. M., Sinha, N., Shaha, A. R., Divgi, C. R., Pentlow, K. S., Ghossein, R. A., & Tuttle, R. M. (2002) · PubMed · Cited by 150
Leeper, R. D. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-6-1143 · Cited by 144
Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis
Links, T. P., van Tol, K. M., Jager, P. L., Plukker, J. T. M., Piers, D. A., Boezen, H. M., Dullaart, R. P. F., de Vries, E. G. E., & Sluiter, W. J. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00892 · Cited by 142
Cap, J., Ryška, A., Řehořková, Hovorková, E., Kerekes, & Pohnětalová (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00847.x · Cited by 138
Optimal treatment strategy in patients with papillary thyroid cancer: A decision analysis
Esnaola, N. F., Cantor, S. B., Sherman, S. I., Lee, J. E., & Evans, D. B. (2001) · Surgery · doi:10.1067/msy.2001.118370 · Cited by 132
Fatourechi, V., HAY, I. D., Mullan, B. P., Wiseman, G. A., Eghbali-Fatourechi, G., Thorson, L. M., & Gorman, C. A. (2000) · Thyroid · doi:10.1089/thy.2000.10.573 · Cited by 132
Nahas, Z., Goldenberg, D., Fakhry, C., Ewertz, M., Zeiger, M. A., Ladenson, P. W., Wahl, R. L., & Tufano, R. P. (2005) · The Laryngoscope · doi:10.1097/01.mlg.0000154725.00787.00 · Cited by 129
Schlumberger, M. J., Charbord, P., Fragu, P., Lumbroso, J., Parmentier, C., & Tubiana, M. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-513 · Cited by 128
Self-citationBraga, M., Cavalcanti, T. C. S., Collaço, L. M., & Graf, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7824 · Cited by 125
Detection of Thyroid Remnant/Metastasis Without Stunning: An Ongoing Dilemma
PARK, H.-M., Park, Y. H., & Zhou, X. (1997) · Thyroid · doi:10.1089/thy.1997.7.277 · Cited by 124
Prognostic Importance of Vascular Invasion in Papillary Thyroid Carcinoma
Gardner, R. E., Tuttle, R. M., Burman, K. D., Haddady, S., Truman, C., Sparling, Y. H., Wartofsky, L., Sessions, R. B., & Ringel, M. D. (2000) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.126.3.309 · Cited by 121
Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.
Laßmann, M., Luster, M., Hänscheid, H., & Reiners, C. (2004) · PubMed · Cited by 119
Schlumberger, M. J., Pacini, F., Wiersinga, W. M., Toft, A. D., Smit, J. W. A., Franco, F. S., Lind, P., Limbert, E., Jarząb, B., Jamar, F., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510539 · Cited by 112
Self-citationChemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-Roussy
Droz, J., Schlumberger, M. J., Rougier, P. R., Ghosn, M., Gardet, P., & Parmentier, C. (1990) · Tumori Journal · doi:10.1177/030089169007600513 · Cited by 110
Self-citationSelf-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I
Hilditch, T., Dempsey, M. F., Bolster, A. A., McMenemin, R. M., & Reed, N. S. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0785-6 · Cited by 107
Ceccarelli, C., Bencivelli, W., Morciano, D., Pinchera, A., & Pacini, F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7719 · Cited by 103
Self-citationBeyond Radioiodine: A Review of Potential New Therapeutic Approaches for Thyroid Cancer
Braga‐Basaria, M., & Ringel, M. D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021863 · Cited by 101
Santini, F., Bottici, V., Elisei, R., Montanelli, L., Mazzeo, S., Basolo, F., Pinchera, A., & Pacini, F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011151 · Cited by 91
Self-citationDifferentiated thyroid cancer long-term impact of initial therapy.
Mazzaferri, E. L., & Jhiang, S. M. (1995) · PubMed · Cited by 88
Randolph, G. W., & Daniels, G. H. (2002) · Thyroid · doi:10.1089/105072502320908321 · Cited by 83
External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer
Ford, D., Giridharan, S., McConkey, C., Hartley, A. G. J., Brammer, C., Watkinson, J. C., & Glaholm, J. (2003) · Clinical Oncology · doi:10.1016/s0936-6555(03)00162-6 · Cited by 79
Pons, F., Carri�, I., Estorch, M., Ginjaume, M., PONS, J., & Milián, R. L. (1987) · Clinical Nuclear Medicine · doi:10.1097/00003072-198708000-00014 · Cited by 71
Clinical use of recombinant human TSH in thyroid cancer patients
Schlumberger, M. J., Ricard, M., & Pacini, F. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430557 · Cited by 69
Self-citationIs Thyroid Hormone Suppression Therapy Prothrombotic?
Horne, M. K., Singh, K. K., Rosenfeld, K. G., WESLEY, R. A., Skarulis, M. C., Merryman, P. K., Cullinane, A., Costello, R., Patterson, A., Eggerman, T. L., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0536 · Cited by 67
Feldt‐Rasmussen, U., Profilis, C., Colinet, E., Black, E. G., Bornet, H., Bourdoux, P. P., Carayon, P., Ericsson, U.-B. C., Koutras, D. A., León, L., et al. (1996) · PubMed · Cited by 66
Self-citationCeccarelli, C., Battisti, P., Gasperi, M., et al. (1999) · PubMed · Cited by 41
Presurgical Serum Thyroglobulin Has No Prognostic Value in Papillary Thyroid Cancer
Guarino, E., Tarantini, B., Pilli, T., et al. (2005) · Thyroid · doi:10.1089/thy.2005.15.1041 · Cited by 36
Two Cases of Thyroid Carcinoma That Were Not Stimulated by Recombinant Human Thyrotropin
Driedger, A. A., & Kotowycz, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031650 · Cited by 36
Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma
Sherman, S. I. (1999) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(199901/02)16:1<34::aid-ssu7>3.0.co;2-2 · Cited by 30
Surgical Management of Advanced Thyroid Cancer Invading the Aerodigestive Tract
Dralle, H. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0139-7.50038-7 · Cited by 20
Self-citation
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationCooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Self-citationStagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Self-citationAlexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Self-citation
Metadata
- Authors
- Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J. W. A., Wiersinga, W., & _, _.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06
- Volume
- 154
- Issue
- 6
- Pages
- 787-803
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2163175491
- Cited by
- 1,976
- References
- 90
- FWCI
- 69.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.